Duchenne muscular dystrophy: EMA sticks to negative vote against Translarna

Amsterdam – The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has again voted against renewing the approval of the drug Translarna, which was developed 10 years ago to